Research Article
Sarcoid-Like Mediastinal Lymphadenopathy in Gynecologic Malignancy
| Age | Primary malignancy | FIGO stage at diagnosis | Sampled LN station | PET scan | PET uptake | Initial chemotherapy | Lymphadenopathy on initial staging CT scan | Duration in which patient was followed after EBUS and remained disease-free |
| 66 | Endometrial Adenocarcinoma | IA | 4R, 7, 12L | Positive | L hilum maximal SUV of 6.6. Infracarinal maximal SUV of 6.9. R hilum maximal SUV of 6.2 | No chemotherapy advised | Mediastinal lymphadenopathy present on initial staging CT | 2 years |
| 68 | Serous ovarian carcinoma | IIIB | 7 and 11R | Positive | R hilar maximal SUV of 3.7 | Taxol IV, Cisplatin intraperitoneal, and Taxol intraperitoneal | None | 1 year |
| 33 | Serous ovarian carcinoma | IIIA | 4R, 7, 11R | N/A | N/A | Taxol/Cisplatin chemotherapy | None | 3 years |
| 67 | Serous fallopian carcinoma | IIIC | 4R, 7, 10R | N/A | N/A | N/A | None | N/A |
| 58 | Endometrial Adenocarcinoma | IC | 4R, 7, 11R | N/A | N/A | N/A | None | 4 years |
|
|